About this trial
The purpose of this prospective randomized controlled clinical trial is to evaluate the effect of suprascapular nerve block on shoulder joint proprioception in stroke patients with hemiplegic shoulder pain.
Fourteen patients aged 18-80 years with hemiplegic shoulder pain will be randomized into two groups. One group will receive suprascapular nerve block followed by a standardized physical therapy program, while the control group will receive the same physical therapy program alone.
The primary outcome is shoulder joint proprioception. Secondary outcomes include pain intensity, shoulder range of motion, motor recovery, stroke-specific quality of life, and upper extremity functional outcomes.
The results of this study are expected to clarify the role of suprascapular nerve block on proprioception and rehabilitation outcomes in patients with hemiplegic shoulder pain.
Eligibility criteria
Qualifiers
Age between 18 and 80 years
Presence of shoulder pain on the hemiplegic side with a Numeric Rating Scale (NRS) score > 3
At least 1 month since the cerebrovascular event (subacute and chronic stroke patients)
Active shoulder flexion range of motion > 90 degrees (required for the application of the laser pointer-assisted joint position sense test)
Disqualifiers
Mini-Mental State Examination score < 24 indicating cognitive impairment
Presence of aphasia
Shoulder spasticity with a Modified Ashworth Scale score > 2
Brunnstrom upper extremity motor stage < 3
Trial design
Treatments tested in this trial
- suprascapular nerve block
- physical therapy